| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
2 Respiratory Unit and 4 Ergonomics Dept, Istituto Scientifico di Montescano and Respiratory Units, Istituto Scientifico di, 3 Gussago and 1 Pavia, Fondazione S. Maugeri Istituto Ricovero e Cura a Carattere Scientifico, Pavia, Italy
CORRESPONDENCE: S. Nava, Respiratory Unit, Fondazione S.Maugeri, Via Ferrata 8, 27100, Pavia, Italy. Fax: 39 0382592075. E-mail: snava@fsm.it
Keywords: lung rejection, phrenic nerve stimulation, respiratory muscle, skeletal muscle, weakness
Received: February 28, 2002
Accepted March 11, 2002
Abstract
There have been occasional reports of acute respiratory and skeletal muscle weakness in intensive care unit patients treated with massive doses of corticosteroids. However, in this setting the concomitant use of other drugs may have influenced the finding.
In this study the effects of 5 days of treatment with high doses of steroids in consecutive patients with acute lung rejection after transplantation were systematically evaluated. Maximal inspiratory pressure during phrenic nerve stimulation and peak torque of isokinetic contraction of the quadriceps and hamstring muscles were measured objectively.
Compared to the pretreatment condition,
This demonstrates muscle weakness induced by steroids within patients.
45% of patients showed acute generalised muscle weakness that recovered after 2 months.
Methods
Over a 6-yr period (1992–1998) the inotropic properties of the respiratory and limb muscles in consecutive patients developing acute rejection after a single or double lung transplant were studied. Table 1
shows the main clinical and physiological characteristics of the 13 patients enrolled. The study was approved by the local Ethics Committee and informed consent to the study was given by each patient. When acute rejection was determined, both clinically and histologically, the patients followed a protocol consisting of 12 mg·kg–1 of methylprednisolone for 3 consecutive days and 10 mg·kg–1 for the next 2 days. Additional immunosuppressive drugs were started after this period only in the case of steroid-resistant acute rejection.
|
Skeletal muscle function was assessed by the peak torque of isokinetic contraction at a test speed of 120 s–1 of the flexor (hamstring; IFX) and extensor (quadriceps; IEX) muscles of the leg, measured by an isokinetic dynamometer.
All the above mentioned measurements, together with pulmonary function tests (PFT), were recorded immediately before the first bolus of methyprednisolone and 24 h after the last administration.
The individual relationships between the Pmt amplitude as a function of the voluntary inspiratory effort on which electrical stimulation was superimposed showed that in most cases (10 of 13) no twitch could be detected during maximal efforts indicating that all stimulated motor units were fully activated. The maximum pressures predicted (MIPp) from the twitch occlusion were calculated using the following equation:
|
| (001) |
Results
At the time of rejection MIPp was overall markedly reduced (43±13% of predicted). Figure 1a illustrates the individual changes in MIPp before and after the 5-day course of steroids. Six of the 13 patients showed a clear decrease (>15%) in maximal inspiratory pressure after steroid treatment; these findings were not correlated with body mass index, age or type of surgery, but four of these six patients were affected by congenital or secondary pulmonary hypertension. Functional residual capacity, the main determinant in the assessment of the inotropic characteristic of the inspiratory muscle, was identical (3.56±0.54 versus 3.69±0.61 L) before and after the treatment, as were the other PFTs. At the time of rejection IFX and IEX were also overall markedly reduced (53±11 and 58±9 of predicted, respectively). Figure 1b showed that in four out of nine patients able to complete the peak torque test, IEX was decreased >15% after the treatment. In these patients (except one) changes in MIPp closely paralleled those in IFX and IEX. Both skeletal and respiratory muscle strength fully recovered after 52±13 days. All the patients survived the episode of rejection. The mean time of survival from enrolment into the study in the patients not showing respiratory muscle weakness was 63±18 months whereas it was 45±12 months for the remaining patients.
|
There have been occasional reports of generalised weakness occurring in patients treated with massive doses of corticosteroids, sometimes interfering with the process of weaning from mechanical ventilation. However, intensive care unit patients are also likely to be treated with other drugs (antibiotics, muscle relaxants) which have been shown to produce massive neurogenic changes and rhabdomyolysis, so it is not possible to determine the significance of these findings 5. The current authors' observations give the first systematic clinical demonstration that a high dose of steroids for only 5 days, in the absence of other therapy, induces profound respiratory and limb muscle weakness, at least in some individuals. The large majority of these patients already manifested a marked reduction in MIPp, IFX and IEX at the time of the acute rejection because they were still recovering from the surgical procedure and probably the effects of prolonged bed-rest and/or limited physical activity prior to the surgery. The occurrence of generalised muscle weakness is likely to be related to myopathy which, when it develops on a chronic basis, may also influence the survival of the patients 6, even though in most of the patients in this study full recovery was observed 2 months after the treatment.
These data demonstrate that short-term treatment with high doses of steroids can lead to generalised muscle weakness, thus further hampering the patient's prompt clinical recovery after rejection of an allograft.
References
This article has been cited by other articles:
|
|
 |
|
  D. S. Hui, K. T. Wong, F. W. Ko, L. S. Tam, D. P. Chan, J. Woo, and J. J.Y. Sung The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors Chest, October 1, 2005; 128(4): 2247 - 2261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D S Hui, G M Joynt, K T Wong, C D Gomersall, T S Li, G Antonio, F W Ko, M C Chan, D P Chan, M W Tong, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors Thorax, May 1, 2005; 60(5): 401 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Pinet, P Scillia, M Cassart, M Lamotte, C Knoop, C Melot, and M Estenne Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis Thorax, September 1, 2004; 59(9): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.S. Hopkinson, W.D-C. Man, M.J. Dayer, E.T. Ross, A.H. Nickol, N. Hart, J. Moxham, and M.I. Polkey Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease Eur. Respir. J., July 1, 2004; 24(1): 137 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Laghi and M. J. Tobin Disorders of the Respiratory Muscles Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zanotti, G. Felicetti, M. Maini, and C. Fracchia Peripheral Muscle Strength Training in Bed-Bound Patients With COPD Receiving Mechanical Ventilation: Effect of Electrical Stimulation Chest, July 1, 2003; 124(1): 292 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nava From the Author Eur. Respir. J., February 1, 2003; 21(2): 378 - 378. [Full Text] [PDF]
|
|
|
|
|
|
C.D. Shee Muscle weakness after short course of steroids Eur. Respir. J., February 1, 2003; 21(2): 377 - 378. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
